Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 583.67 million compared to CNY 819.27 million a year ago. Revenue was CNY 584.14 million compared to CNY 820.87 million a year ago.

Net income was CNY 93.75 million compared to CNY 216.02 million a year ago. Basic earnings per share from continuing operations was CNY 0.6962 compared to CNY 2.0262 a year ago. Diluted earnings per share from continuing operations was CNY 0.6962 compared to CNY 2.0262 a year ago.